Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000240579 corresponds to a human pseudogene that resembles part of the sequence of CD2 (cytoplasmic tail) binding protein 2, a protein involved in T cell activation and RNA splicing[1][3][4]. This genomic region does not produce a functional protein product, and there is no evidence for direct biological or therapeutic relevance[1][3]. Pseudogenes are typically evolutionary remnants of genes and do not participate in cellular pathways or disease mechanisms, nor do they serve as drug targets or biomarkers[1][10].
None. No known mechanisms, as pseudogenes do not express targetable proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of CD2 (cytoplasmic tail) binding protein 2 (ENSG00000240579).